Cure for cancer? UK scientists are creating a vaccine that could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 y ...
labiotech42m
U.K. biotech defies the odds, raising £3.5B in 2024
The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.
MarketWatch19h
GSK PLC ADR
Teva Pharmaceutical Industries Ltd. ADR-3.78% $21.4B ...